Breast cancer is usually a form of tumor that can be visualized through x-ray or felt as a lump. The cancer can be either benign which results in the abnormal growth in the breast area or metastatic that can invade the distant areas of the body. Breast cancer screening is conducted to detect the signs & symptoms of breast cancer. Breast cancer screening does not prevent the disease. However, detection in early stage increases the chances of recovery from the disease. Breast cancer screening tests are offered to women aged between 50-70 years as they are more prone to the disease.
Breast Cancer Screening Tests Market: Segmentation
Breast cancer screening tests market can be segmented on the basis of various tests conducted on a patient to detect the disease, which include:
Breast cancer screening tests can be segmented on the basis of end users which is as follows:
Breast Cancer Screening Tests Market: Dynamics
Breast Cancer Screening Tests Market is primarily driven by a few key factors such as the patient awareness regarding rising healthcare concerns, increasing research for detection of various types of cancers, and prevention of disease. In addition to this, Breast Cancer Screening Tests Market also observes significant growth due to different government initiatives and public awareness campaigns.
Breast Cancer Screening Tests Market, however, faces various challenges since patients going through biopsies spend a lot for early detections. Also, MRI scans are accurate however are time-consuming and expensive.
Breast Cancer Screening Tests Market: Region-wise Outlook
Based on geography, the Breast Cancer Screening Tests Market can be segmented into five major regions: North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa. At present, North America holds a leading position in the Breast Cancer Screening Tests Market followed by Europe. The major driving factors which have affected the growth of Breast Cancer Screening TestsMarket in this region is constantly increasing regulatory scenario monitored by various organizations, such as World Health Organization (WHO) for safety and health issues and pressure on healthcare institutions to reduce the number of deaths from breast cancers by early detection. Following North America, European countries are also anticipated to show steady growth in the Breast Cancer Screening Tests Market. Asia-Pacific region has improved its healthcare scenario by innovative campaigns on breast cancer awareness and has emerged as a major player in Breast Cancer Screening Tests Market. The factors which are expected to fuel the growth of Breast Cancer Screening Tests Market in Asia-Pacific are increased initiatives from various government & non-government organizations, rising healthcare concerns, and improving healthcare scenario of the region. Breast Cancer Screening Tests Market is also anticipated to evolve at a rapid rate across the regions. However, North America is expected to maintain its position in the overall Breast Cancer Screening Tests Market.
Breast Cancer Screening Tests Market: Key Players
Breast Cancer Screening Tests Market holds a huge number of players operating in the segment for years with expertise and experience. Some of the major players operating in the Breast Cancer Screening Tests Market are GE Healthcare, Hologic Inc., Siemens Healthcare GmbH, Allengers Infotech, Carestream Health., Philips Healthcare, Shimadzu Corporation, Toshiba Medical Systems Corporation, Hitachi Medical Corporation, Esaote, Agilent Technologies, Hitachi Medical Corporation (HMC) and many others. Breast Cancer Screening Tests Market has a presence of many regional players which have a huge market share in emerging countries.